The tech business can be a bit of a roller coaster. Some years our budgets might grow 20 percent. Other years we need to cut 15 percent. And to state the obvious, it was ...
CYFIRMA, the global leader in Preemptive External Threat Landscape Management (ETLM), today announced the launch of DeCYFIR 4.0, a groundbreaking evolution of ...
Exotech, a Saudi-based emerging technologies company, today announced the launch of SOC AI, an advanced AI-powered autonomous threat response platform designed to transform how organizations detect, ...
Nicolás Maduro is a Venezuelan politician, born in 1962, who rose through the Chavist movement as one of the closest allies ...
An Iranian protester throwing an object at a government building during a demonstration in Fasa on Dec. 31, 2025.Three years ...
Not only war but also a U.S. prioritization of the Kurdistan Regional Government's stability over decades has accelerated the ...
$70 Million Buybacks Failed to Save Jupiter: Solana Co-Founder Explains Why The Token Strategy Broke
Jupiter’s $70M buybacks failed to offset massive token unlocks as Solana’s cofounder questions traditional crypto repurchase strategies.
Chanhassen, MN held a public hearing on the proposed 2026 budget and tax levy, focusing on transparency and planning.
Congresswoman Escobar opposes Trump's military action in Venezuela, calling it illegal and criticizing motives behind it.
Genmab A/S (Nasdaq: GMAB) announced today that it will discontinue further clinical development of acasunlimab. This decision was made as part of Genmab’s strategic focus on the most value‑creating ...
In November, San Diego received 2,442 requests for a bed, according to Casey Snell, a senior vice president at the housing ...
Genmab to discontinue clinical development of acasunlimab following a portfolio review Decision reflects prioritization of higher‑impact opportunities across Genmab’s late‑stage pipeline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback